BakerHosts

Congratulations! Your team has made a critical discovery based on its analysis of your company’s clinical data. You want to file a patent application so that your company can secure patent rights for that discovery. Simple, right? Wrong. Patenting clinical stage inventions requires planning and strategizing to give the patent application its best chance of success. Stephanie Lodise discusses what companies should think about when drafting clinical stage invention patent applications that satisfy the US “novelty” requirement of patentability.

Questions & Comments: [email protected]

What comes to mind when you think of “hot topics” in patent law? Subject matter eligibility? Obviousness? Damages? Quietly, administrative law has moved to the top of the list of issues that consume the attention of the Court of Appeals for the Federal Circuit and the Supreme Court in patent cases. This podcast will explain how that happened, what to expect in the future, and what lessons we can learn and apply in patent disputes.

Questions & Comments: [email protected]

Partners Ann O’Brien and Jeewon Serrato discuss the how the lines between antitrust and privacy objectives and enforcement are becoming increasingly blurred, and the implications for companies holding large amounts of data. The speakers describe real-world scenarios in which companies need to find ways to compete, innovate and serve customers while navigating antitrust and privacy issues.

Questions & Comments: 

[email protected], [email protected]

The Pandemic has fast-tracked the use of telehealth services. Hussein Akhavannik discusses how medical device companies are looking to add to or expand remote monitoring capabilities. However, some capabilities raise legal concerns.

Questions & Comments: [email protected]

Employees showing support for social justice movements are starting to wear their advocacy positions on their sleeve – or on their face coverings or t-shirts. Who gets to decide what is offensive and what is not, and how should employers decide what is allowed? Join Eric Barnum and Todd Lebowitz as they address these issues and provide a thoughtful and timely discussion relevant to many employers.

Questions & Comments: 

[email protected], [email protected]

Pharmaceutical companies only need patents for compositions of matter and general methods of use, right? Wrong. Discoveries can happen well into Phase III and IV and pharmaceutical companies should seek patent protection for those later-developed inventions. Partner and co-leader of the Biotechnology, Chemical, and Pharmaceutical patent prosecution team, Stephanie Lodise discusses how and why clinical stage patent protection can drive innovation in small molecule pharmaceutical development.

Questions & Comments: [email protected]

Just how much impact is the global pandemic having on foreign national workers and business immigration? Matt Hoyt addresses this question and gives us a breakdown of which foreign national workers are most at risk and how companies can prepare for possible slowdowns in application processing. Matt is a partner in BakerHostetler’s Labor and Employment Group and leads our Immigration practice.

Questions & Comments: [email protected]